Patent ID: 11939307
Assignee: INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 11:
12. The compound or the pharmaceutically acceptable salt thereof as claimed in claim 2, wherein the heterocyclyl is pyrrolidinyl; wherein the three-membered cyclic group is aziridinyl, the four-membered cyclic group is azetidinyl, the five membered cyclic group is selected from the group consisting of pyrrolyl, pyrrolidinyl, imidazolyl, and oxazolyl, the six-membered cyclic group is selected from the group consisting of morpholinyl, piperazinyl, piperidinyl, pyridinyl, and pyrimidinyl, and the seven-membered cyclic group is 1,4-diazepanyl; the alkyl containing 1-4 carbon is methyl or ethyl; wherein the di-C1-C4 alkylamino is dimethylamino or diethylamino; and saturated heterocyclic groups containing one nitrogen are selected from the group consisting of cyclopropanyl and pyrrolidinyl.